ADURO CLEAN TECHNOLOGIES INC.

Recent Developments

Since late 2023, the Company has focused on advancing validation and commercialization of its HCT platform through technology development, pilot operations and customer engagement activities. In addition to the foregoing, other key developments of the Company include:

1. NGP Pilot Plant commissioning and operations - During fiscal 2026, the Company completed commissioning of its NGP Pilot Plant and transitioned the facility into initial operating campaigns. The NGP Pilot Plant is now operating as an integrated system supporting continuous processing, data generation and process optimization, including longer-duration operating campaigns intended to support scale-up and commercialization activities and to generate data to support scale-up and commercialization planning.

2. Pilot plant development and scale-up program - The Company has completed engineering design and construction activities for its pilot-scale systems and continues to generate operational data intended to support scale-up to demonstration and commercial systems , including process validation, performance optimization and evaluation under integrated operating conditions.

3. FOAK Plant development - The Company has completed the basic design of its FOAK Plant, selected key engineering partners and vendors, and advanced site evaluation activities , including identification of potential locations and site characteristics. Construction is expected to begin in early 2026, with commissioning targeted for early calendar year 2028. The FOAK Plant is intended to validate scalability of the HCT platform and support the Company's transition toward commercial deployment.

4. Customer engagement and industry collaboration - The Company continues to advance its Customer Engagement Program, working with industry participants across petrochemical, waste management and industrial sectors to evaluate the application of its technology on real-world feedstocks. These engagements are intended to support technology validation and guide commercialization and potential future licensing opportunities.

5. Expansion of testing scope and feedstock validation - Customer programs and internal research have expanded to include more complex and contaminated materials, including mixed plastics and industrial waste streams, supporting validation of the flexibility of the HCT platform across a broader range of feedstocks and operating conditions.

6. Strategic collaborations and development activities - The Company has entered into collaborations and memoranda of understanding with various industry participants to support pilot plant operations, feedstock sourcing, engineering development and demonstration-scale planning; however, these arrangements are generally at the evaluation or development stage.

7. European expansion - The Company established a European subsidiary to support commercialization activities in Europe and continues to evaluate development of a demonstration facility in the region, including potential integration with existing industrial infrastructure.

While these activities are intended to support commercialization, the Company does not currently have any definitive commercial partnership agreements in place.